Several studies have shown an enrichment of alpha-synuclein at the IMM under pathological conditions, including in PD brain, which has been linked to its interaction with the mitochondrial-specific phospholipid, cardiolipin (Devi et al., 2008; Nakamura et al., 2011; Robotta et al., 2014). Here, SNCA is linked to Parkinson disease.